Insights

Rapid expansion Nucleus Biologics is actively launching new products and systems such as the Krakatoa K500 pod-based closed system and the CRAIC Formulation Finder, indicating opportunities to upsell scalable media solutions and AI-assisted formulation services to research sites expanding their cell culture capacity.

AI powered With NB-Lux AI and CRAIC Formulation Finder, the company emphasizes AI and digital workflow integration for media and buffer development, presenting a cross-sell path for customers seeking digital batch records, predictive analytics, and automated formulation support.

Integrated platforms The suite of platforms including QuickStart Media, optimized formulations, and integrated automation suggests potential to bundle media, buffers, and digital tooling for end-to-end cell culture workflows, appealing to labs aiming to reduce cycle times and improve reproducibility.

Global collaboration Strategic partnerships such as with Core Biogenesis highlight opportunities to expand distribution and co-developed reagents or media across regions, enabling sales teams to target international customers in France, California, and beyond.

Sustainability focus Nucleus Biologics’ goal to reduce environmental footprint in cell culture aligns with buyers seeking greener operations, presenting a marketing and upsell angle for sustainable media, waste-reduction services, and compliant, low-impact production options.

Similar companies to Nucleus Biologics

Nucleus Biologics Tech Stack

Nucleus Biologics uses 8 technology products and services including HubSpot Analytics, Microsoft Power Platform, WordPress, and more. Explore Nucleus Biologics's tech stack below.

Media & News

Nucleus Biologics's Email Address Formats

Nucleus Biologics uses at least 4 email formats:
Nucleus Biologics Email FormatsExamplePercentage
FLast@nucleusbiologics.comJDoe@nucleusbiologics.com
94%
Last@nucleusbiologics.comDoe@nucleusbiologics.com
3%
First.Last@nucleusbiologics.comJohn.Doe@nucleusbiologics.com
2%
FMiddleLast@nucleusbiologics.comJMichaelDoe@nucleusbiologics.com
1%

Frequently Asked Questions

What is Nucleus Biologics's official website and social media links?

Minus sign iconPlus sign icon
Nucleus Biologics's official website is nucleusbiologics.com and has social profiles on LinkedIn.

How much revenue does Nucleus Biologics generate?

Minus sign iconPlus sign icon
As of October 2026, Nucleus Biologics's annual revenue is estimated to be $25M - $50M.

What is Nucleus Biologics's SIC code and NAICS code?

Minus sign iconPlus sign icon
Nucleus Biologics's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Nucleus Biologics have currently?

Minus sign iconPlus sign icon
As of October 2026, Nucleus Biologics has approximately 45 employees across 2 continents, including North America and Asia. Key team members include Senior Vice President Of Commercial: K. N., Director Of Business Development And Strategic Alliance: A. L. and Quality Assurance Manager: A. L. Explore Nucleus Biologics's employee directory with LeadIQ.

What industry does Nucleus Biologics belong to?

Minus sign iconPlus sign icon
Nucleus Biologics operates in the Biotechnology Research industry.

What technology does Nucleus Biologics use?

Minus sign iconPlus sign icon
Nucleus Biologics's tech stack includes HubSpot Analytics, Microsoft Power Platform, WordPress, Shopify, WooCommerce, Atlassian Jira, Smartsheet and Piwik.

What is Nucleus Biologics's email format?

Minus sign iconPlus sign icon
Nucleus Biologics's email format typically follows the pattern of FLast@nucleusbiologics.com. Find more Nucleus Biologics email formats with LeadIQ.

When was Nucleus Biologics founded?

Minus sign iconPlus sign icon
Nucleus Biologics was founded in 2016.
Nucleus Biologics logo

Nucleus Biologics

Biotechnology ResearchCalifornia, United States11-50 Employees

Nucleus Biologics is a San Diego-based biotechnology company that supplies media and supplements for the cell and gene therapy sector on a global scale. The firm emphasizes precision cell culture and aims to shorten the time from scientific discovery to cure. It provides transparent, cGMP-compliant products and services and seeks to modernize practices in the field while reducing the environmental footprint of cell culture.

Positioned within the Biotechnology Research industry as a global supplier of GMP-grade media and buffers for advanced therapies, the company serves researchers and clinicians working in cell and gene therapy. Based in San Diego, it operates as a mid-sized company with an international customer footprint. In May 2026, Nucleus Biologics announced NB-Lux AI, an AI-enabled digital ecosystem intended to streamline media and buffer manufacturing from formulation to finished product.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $25M - $50M

    Nucleus Biologics's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.